Date
- 2024 (29)
- 2023 (48)
- 2022 (26)
- 2021 (102)
- 2020 (61)
- 2019 (127)
- 2018 (41)
- 2017 (23)
- 2016 (26)
- 2015 (14)
- 2014 (22)
- 2013 (8)
- 2012 (3)
- 2010 (2)
- 2009 (12)
- 2008 (6)
- 2007 (12)
- 2006 (12)
- 2005 (15)
- 2004 (5)
- 2003 (3)
- 2002 (7)
- 2001 (4)
- 2000 (12)
- 1999 (5)
- 1998 (4)
- 1997 (1)
- 1996 (10)
- 1995 (2)
- 1994 (6)
- 1993 (6)
- 1991 (23)
Results for
"[search-keyword]"
Sponsor content
677 result(s) found, displaying 401 to 410
-
LOVENOX enoxaparin sodium 40 mg/0.4 mL injection ampoule Cancelled under Section 30(1)(c) of the Act
Cancellation by sponsorRequested by Sanofi-Aventis Australia Pty Ltd -
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PRALUENT alirocumab (rch) 75mg/mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PRALUENT alirocumab (rch) 150mg/mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PRALUENT alirocumab (rch) 75mg/mL solution for injection, pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PRALUENT alirocumab (rch) 150mg/mL solution for injection pre-filled pen.
-
Prescription medicine registrationActive ingredients: sarilumab (rch).
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Sarilumab (rch)
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Dupilumab
-
Cancellation by sponsorRequested by Sanofi-Aventis Australia Pty Ltd